Intervention Review

Phosphodiesterase III inhibitors for heart failure

  1. Emmanuel Amsallem1,
  2. Christelle Kasparian2,
  3. G Haddour3,
  4. Jean-Pierre Boissel4,
  5. Patrice Nony5,*

Editorial Group: Cochrane Heart Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 1 NOV 2004

DOI: 10.1002/14651858.CD002230.pub2

Database Title

Additional Information

How to Cite

Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002230. DOI: 10.1002/14651858.CD002230.pub2.

Author Information

  1. 1

    CETAF, Quality - Evaluation - Etudes, Saint-Etienne Cedex 02, France

  2. 2

    APRET/EZUS, Clinical Pharmacology Unit (EA 3736), Lyon, France

  3. 3

    Hospices Civils de Lyon, Cardiovscular Hospital Louis Pradel, Lyon, France

  4. 4

    Hopital Cardio-Vasculaire et Pneumologique Louis Pradel, Centre d'Investigation Clinique - CIC de Lyon, Bron, CEDEX, France

  5. 5

    Hopital Neurocardiologique, Lyon, France

*Patrice Nony, Hopital Neurocardiologique, 28 avenue Doyen Lepine, Lyon, 69003, France. pn@upcl.univ-lyon1.fr.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (450K)Full (753K)

  1. Current Version

    Phosphodiesterase III inhibitors for heart failure

    Emmanuel Amsallem, Christelle Kasparian, G Haddour, Jean-Pierre Boissel and Patrice Nony

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD002230.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Phosphodiesterase III inhibitors for heart failure

    P Nony and F Martin

    Article first published online: 18 OCT 2004 | DOI: 10.1002/14651858.CD002230

View Full Article (HTML) Summary (58K)Standard (450K)Full (753K)